Vistin Pharma ASA (0RAM) Financial Statements
Vistin Pharma ASA Financial Overview
Vistin Pharma ASA's market cap is currently $815.94M. The company's EPS TTM is ―; its P/E ratio is 13.46; Vistin Pharma ASA is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 131.88M | $ 142.94M | $ 109.35M | $ 90.46M | $ 79.59M |
| Operating Income | $ 33.25M | $ 45.56M | $ 16.77M | $ -4.61M | $ 14.02M |
| EBITDA | $ 42.96M | $ -113.83M | $ 93.22M | $ -79.79M | $ 11.99M |
| Net Income | $ 24.87M | $ -96.95M | $ 66.20M | $ -73.63M | $ 70.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 333.15M | $ 321.92M | $ 504.17M | $ 500.06M | $ 231.75M |
| Total Debt | $ 0.00 | $ 0.00 | $ 1.22M | $ 0.00 | $ 0.00 |
| Net Debt | $ -35.75M | $ -77.04M | $ -318.45M | $ -320.73M | $ -69.38M |
| Total Liabilities | $ 57.38M | $ 49.51M | $ 90.77M | $ 151.21M | $ 111.59M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -18.26M | $ -198.83M | $ 580.00K | $ -57.55M | $ -26.04M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD